Other
May 2025Forever Labs spun out SuperShot Inc. as an independent company and appointed Kevin Virgil CEO of Forever Labs; the founders moved to lead SuperShot.
SourceWe bank your stem cells to help you live healthier, longer.
Company research
Public company, workplace, funding, and market signals
Overview
Forever Labs is a regenerative medicine and longevity company that banks and cryopreserves a patient’s own adult stem cells for future autologous therapies, working through a board-certified physician network and ISO-accredited biobanking.
Primary product
Adult stem cell banking and future stem-cell expansion services
Founded
2015
Headquarters
Ann Arbor, Michigan, United States
Team size
1-10 employees
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
Stem cell banking and regenerative medicine
Offices
Ann Arbor, Michigan, United States
Jupiter, Florida, United States
New York, New York, United States
San Francisco, California, United States
Los Angeles, California, United States
Business model
Direct-to-consumer membership/subscription
B2B2C physician and clinic network
Biobanking and long-term storage services
Future cell expansion / therapeutic enablement
Funding
Stage
Seed
Total raised
$3.5M
Latest round
Seed · May 2018
Latest amount
$2M
People & investors
Leadership
CEO
Chief Marketing Officer
Laboratory Director
Chief Medical Officer
Mark Katakowski, PhD
Co-Founder & Chief Scientific Officer
Work & culture
Science-first and evidence-based, with recurring company messaging that emphasizes following the science, not the hype. The team appears mission-driven around longevity and regenerative medicine, with close collaboration between clinicians, providers, and biobank operations.
Work style
Onsite
Product & market
Pricing
Membership / annual storage subscription with a lifetime prepaid option; discounted procedure-specific plans for orthopedic and aesthetic partner-clinic referrals.
Differentiators
- —Autologous adult stem-cell focus
- —ISO-accredited biobanking
- —Nationwide physician/provider network
- —Physician-coordinated collection and future activation
- —Patented dynamic cell expansion and bone marrow aspiration
- —Client app with 'Cellfie' sample photos
- —HSA/FSA eligibility
- —Culture expansion and long-read DNA sequencing roadmap
Technology
Node.js
Python
PostgreSQL
AWS
Next.js
HubSpot Chat
Mailchimp
Microsoft Clarity
Hotjar
iCIMS
Calendly
Olark
Cloudflare
Shogun
Facebook Pixel
LinkedIn Insights
Envoy
Customers
Patients seeking stem cell banking for future autologous therapies
Orthopedic and sports-medicine patients
Aesthetic / body-contouring patients
Board-certified physicians and partner clinics
Longevity and regenerative medicine consumers
Competitors
StemCyte
Vita 34
Acorn
StemBioSys
Celltex
Cryo-Cell
Mesoblast
Asymmetrex
Scale & contact
Estimated revenue
$1M-$10M
Signals & risks
Latest news
PR Newswire · Jun 2026
Announced a partnership to combine AcCELLerated Biologics’ distribution with Forever Labs’ stem-cell collection, storage, and planned expansion services, with initial focus on physician education and Florida clinics.
Forever Labs blog · Apr 2026
Announced a partnership to capture adipose tissue from aesthetic procedures and bank stem cells for future use, including regenerative and orthopedic applications.
Forever Labs blog · Mar 2026
Covers a webinar with the Michigan Center for Regenerative Medicine and describes Forever Labs’ upcoming culture-expansion lab as a way to increase cell dose for future therapies.
Forever Labs blog · Jan 2026
Explains the company’s view of shifting state-level regulatory frameworks, expanding domestic manufacturing, and its planned culture-expansion facility in Jupiter, Florida.
PR Newswire · May 2025
Forever Labs spun out SuperShot Inc. as an independent company and named Kevin Virgil CEO of Forever Labs. The founders shifted to lead SuperShot while Forever Labs continued stem-cell preservation and therapeutics.
Jobs and careers at Forever Labs
0 jobs at Forever Labs
No open positions
Check back later for new openings